These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 9011644)
1. Interactions of dynorphin A and related peptides with cardiac ouabain binding sites. Dumont M; Lemaire S J Mol Cell Cardiol; 1996 Mar; 28(3):615-21. PubMed ID: 9011644 [TBL] [Abstract][Full Text] [Related]
2. Characterization of non-opioid [3H]dynorphin A-(1-13) binding sites in the rat heart. Dumont M; Lemaire S J Mol Cell Cardiol; 1993 Aug; 25(8):983-91. PubMed ID: 7903402 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the high affinity [3H]nociceptin binding site in membrane preparations of rat heart: correlations with the non-opioid dynorphin binding site. Dumont M; Lemaire S J Mol Cell Cardiol; 1998 Dec; 30(12):2751-60. PubMed ID: 9990545 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of dynorphin-A on norepinephrine uptake by cardiac synaptosomal-mitochondrial fractions. Dumont M; Lemaire S J Cardiovasc Pharmacol; 1995 Apr; 25(4):518-23. PubMed ID: 7596117 [TBL] [Abstract][Full Text] [Related]
5. Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2. Vig BS; Zheng MQ; Murray TF; Aldrich JV J Med Chem; 2003 Sep; 46(19):4002-8. PubMed ID: 12954053 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the alpha +-like Na+,K+-ATPase which mediates ouabain inhibition of adrenergic induction of N-acetyltransferase (EC 2.3.1.87) activity: studies with isolated pinealocytes. González-García C; Ceña V; Klein DC Mol Pharmacol; 1987 Dec; 32(6):792-7. PubMed ID: 2826993 [TBL] [Abstract][Full Text] [Related]
7. Nonopioid motor effects of dynorphin A and related peptides: structure dependence and role of the N-methyl-D-aspartate receptor. Shukla VK; Prasad JA; Lemaire S J Pharmacol Exp Ther; 1997 Nov; 283(2):604-10. PubMed ID: 9353375 [TBL] [Abstract][Full Text] [Related]
8. Interactions of dynorphin A-(1-13) and nociceptin with cardiac D2 binding sites: inhibition of ischemia-evoked release of noradrenaline from synaptosomal-mitochondrial fractions. Dumont M; Lemaire S J Mol Cell Cardiol; 2000 Aug; 32(8):1567-74. PubMed ID: 10900181 [TBL] [Abstract][Full Text] [Related]
9. Interaction of dynorphin with kappa opioid receptors in bovine adrenal medulla. Dumont M; Lemaire S Neuropeptides; 1985 Jul; 6(4):321-9. PubMed ID: 2864653 [TBL] [Abstract][Full Text] [Related]
10. Na+/K+-ATPase alpha isoforms expression in stroke-prone spontaneously hypertensive rat heart ventricles: effect of salt loading and lacidipine treatment. Quintas LE; Noël F; Wibo M Eur J Pharmacol; 2007 Jun; 565(1-3):151-7. PubMed ID: 17451677 [TBL] [Abstract][Full Text] [Related]
11. Alterations of heart dynorphin-A in the development of spontaneously hypertensive rats. Dumont M; Sabourin L; Lemaire S Neuropeptides; 1990 Jan; 15(1):43-8. PubMed ID: 1970135 [TBL] [Abstract][Full Text] [Related]
12. Decrease in Na+,K+-ATPase activity and [3H]ouabain binding sites in sarcolemma prepared from hearts of spontaneously hypertensive rats. Lee SW; Schwartz A; Adams RJ; Yamori Y; Whitmer K; Lane LK; Wallick ET Hypertension; 1983; 5(5):682-8. PubMed ID: 6311739 [TBL] [Abstract][Full Text] [Related]
13. Kinetics of ouabain binding and changes in cellular sodium content, 42K+ transport and contractile state during ouabain exposure in cultured chick heart cells. Kim D; Barry WH; Smith TW J Pharmacol Exp Ther; 1984 Nov; 231(2):326-33. PubMed ID: 6092615 [TBL] [Abstract][Full Text] [Related]
14. Binding of [3H]-nitrendipine and [3H]-diltiazem to rat myocardial sarcolemma. Miwa N; Kanaide H; Nishimura J; Nakamura M Arzneimittelforschung; 1986 Jul; 36(7):1059-62. PubMed ID: 3021180 [TBL] [Abstract][Full Text] [Related]
15. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors. Zhao GM; Qian X; Schiller PW; Szeto HH J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366 [TBL] [Abstract][Full Text] [Related]
16. Dynorphin A analogs containing a conformationally constrained phenylalanine derivative in position 4: reversal of preferred stereochemistry for opioid receptor affinity and discrimination of kappa vs. delta receptors. Aldrich JV; Zheng QI; Murray TF Chirality; 2001; 13(3):125-9. PubMed ID: 11270320 [TBL] [Abstract][Full Text] [Related]
17. Binding of dihydrodigitoxin to beef and human cardiac (Na+ + K+)-ATPase: evidence for two binding sites in cell membranes. Brown L; Erdmann E Biochem Pharmacol; 1983 Nov; 32(21):3183-90. PubMed ID: 6315020 [TBL] [Abstract][Full Text] [Related]
18. Increased content of immunoreactive Leu-enkephalin and alteration of delta-opioid receptor in hearts of spontaneously hypertensive rats. Dumont M; Lemaire S Neurosci Lett; 1988 Nov; 94(1-2):114-8. PubMed ID: 2853850 [TBL] [Abstract][Full Text] [Related]
19. Dynorphin A(1-8): stability and implications for in vitro opioid activity. Bell KM; Traynor JR Can J Physiol Pharmacol; 1998 Mar; 76(3):325-33. PubMed ID: 9673796 [TBL] [Abstract][Full Text] [Related]
20. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma. Castanas E; Giraud P; Audigier Y; Drissi R; Boudouresque F; Conte-Devolx B; Oliver C Mol Pharmacol; 1984 Jan; 25(1):38-45. PubMed ID: 6323951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]